Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Product Name: FOX04-DRI Classification: Senolytic Peptide / p53-FOXO4 Interaction Inhibitor Structural Description: D-retro-inverso peptide targeting FOXO4-p53 protein-protein interaction Molecular Weight: 5358 g/mol Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
Great to have a professional, knowledgeable assessment
plod pku me psobit tak jako rstov faktor pro beta-buky slinivky bin
These findings highlight the potential of this treatment approach in the management of RH but a prospective study is needed to validate its efficacy
However, large visceral deposits in obese women have been linked to suppression of the antilipolytic effect of insulin, and increased levels of free fatty acids have been found in the hepatic portal in individuals with upper body obesity 75,76
